Medtronic's Titan Spine Buyout To Boost Spine Surgery Range
Zacks Investment Research | Jul 01, 2019 09:15PM ET
Medtronic, plc (NYSE:MDT) recently completed the acquisition of titanium spine interbody implant and surface technology company, Titan Spine. The deal’s closure was announced back in May 2019 and is expected to fortify the company’s position in the field of procedural solutions for spine surgery.
Financial terms of the deal were kept under wraps.
Titan Spine currently leads the category of surface-enhanced titanium interbody implants with its unique nanoLOCK platform. Notably, interbody implants are parts that can be inserted between the vertebrae during spinal fusion surgery. This helps relieving pressure on the nerves and holding the vertebrae in place while fusion occurs.
According to Medtronic, the implant material and shape plays a pivotal role in the bone growth process during fusions and currently, titanium interbody devices witness buoyant demand in the spine surgery market.
Medtronic expects this purchase to be strategic for its portfolio as Titan Spine’s surface-enhanced titanium implants when combined with Medtronic’s comprehensive biologics portfolio can improve patient outcomes in spinal procedures.
Financial Impact of the Pact
The buyout is expected to be inconsequential to Medtronic's fiscal 2020 adjusted earnings per share. However, it is estimated to meet Medtronic's long-term financial metrics for acquisitions.
Market Potential in Spine Space
Per a Mordor Intelligence report, the global Spinal Surgery Devices market is projected to reach a value worth $16.6 billion by 2021 at a 5% CAGR from 2016 onward. Taking such abundant prospects into account, we believe, the company’s latest development is a strategic fit.
Medtronic’s Advancement in Spine Arm
In a bid to grow in the field of robotics spine surgery, Medtronic earlier bought Mazor Robotics, an Israel-based robotic surgical guidance systems company, for a consideration of $1.64 billion. Per Medtronic, this consolidation is a calculated move in favor of the company's brisk spine surgery business.
The buyout has combined Medtronic's market-leading spine implants, navigation and intra-operative imaging technology with the acquired company's robotic-assisted surgery (RAS) systems. Following the conclusion of this takeover, Medtronic launched the Mazor X Stealth Edition robotics guidance platform in January and has already received a positive feedback for this integration of best-in-class robotics and navigation capability.
Get The News You Want
Share Price Performance
Over the past year, shares of Medtronic have outperformed its Original post
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.